QT Vascular Ltd. announced that Mr. Momi Mimon Brosh had informed the Company of his intention to resign as the Company's Executive Director to facilitate the reconstitution of the Board following the completion of the Proposed Subscription and Acquisition (details as announced on 13 January 2022), and the Company has accepted his resignation on 13 January 2022. Following this cessation, Momi remains the Chief Executive Officer of TriReme Medical, LLC and continues to manage the existing business of the Company. After having interviewed Mr. Momi Mimon Brosh and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte.

Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the cessation of Mr. Momi Mimon Brosh as the Company's Executive Director.